Improving recommendations for schistosomiasis control interventions using interdisciplinary techniques
In plain English
AI plain-English summaryA single dose of praziquantel, the main drug against schistosomiasis, often fails to clear the infection, and many people avoid taking it because of its side-effects. This project tackles two concrete problems undermining mass drug administration campaigns in affected regions. First, the researcher will identify which individual factors—such as genetics, co-infections, or drug quality—cause praziquantel to work poorly in some people. Second, they will formally evaluate whether taking the drug with food boosts its absorption and reduces side-effects, a practice that has never been rigorously tested. Third, they will survey communities in endemic areas to find out which water, sanitation, and hygiene (WASH) interventions people actually prefer and will use, rather than assuming what works. If successful, the research could directly improve how schistosomiasis control programmes are run. Health officials could tailor drug regimens based on confirmed causes of treatment failure, recommend food co-administration with clear evidence, and invest in WASH measures that communities will adopt. These changes would make mass drug campaigns more effective, reduce reinfection rates, and accelerate progress toward eliminating a disease that sickens hundreds of millions of people. The work is applied and intervention-focused, with no fundamental science component.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
PhD Studentship (Basic)Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know